Stuart Nancy
Insider CIK 1594774 · KALV Director · CNCE Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 14,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 30,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 10,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 10,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 10,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-10-03 | 2024-10-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-09-26 | 2023-09-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 70,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 70,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 68,215 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 51,850 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 21,400 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 80,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 100,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 75,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer | 2023-03-06 | 2023-03-06 | 73,233 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 167,963 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-02-15 | 2023-02-16 | 6,048 | $8.33 | $50.4K | 262,596 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-01-30 | 2023-01-31 | 13,200 | $8.35 | $110.2K | 268,644 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-01-06 | 2023-01-09 | 2,893 | $7.25 | $21.0K | 281,844 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-10-13 | 2022-10-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2022-02-14 | 2022-02-16 | 6,049 | $3.08 | $18.6K | 284,737 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-01-28 | 2022-02-01 | 21,400 | — | $0 | 290,786 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-01-28 | 2022-02-01 | 99,000 | — | $0 | 269,386 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2022-01-05 | 2022-01-07 | 2,894 | $3.19 | $9.2K | 170,386 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-03-18 | 2021-03-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2021-02-16 | 2021-02-17 | 6,049 | $7.32 | $44.3K | 173,280 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2021-01-05 | 2021-01-07 | 51,850 | — | $0 | 51,850 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2021-01-05 | 2021-01-07 | 21,700 | — | $0 | 179,329 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2020-06-22 | 2020-06-24 | 21,238 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2020-06-22 | 2020-06-24 | 10,295 | $11.34 | $116.7K | 157,629 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2020-06-22 | 2020-06-24 | 21,238 | $3.79 | $80.5K | 167,924 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2020-02-14 | 2020-02-19 | 68,215 | — | $0 | 68,215 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2020-02-14 | 2020-02-19 | 45,363 | — | $0 | 146,686 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2019-12-04 | 2019-12-06 | 5,896 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2019-12-04 | 2019-12-06 | 3,416 | $7.61 | $26.0K | 101,323 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2019-12-04 | 2019-12-06 | 5,896 | $4.41 | $26.0K | 104,739 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2019-03-31 | 2019-04-02 | 8,835 | $12.07 | $106.6K | 98,843 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2019-02-06 | 2019-02-07 | 28,616 | — | $0 | 5,896 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2019-02-06 | 2019-02-07 | 28,616 | $4.41 | $126.2K | 116,724 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2019-02-06 | 2019-02-07 | 9,046 | $13.95 | $126.2K | 107,678 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2019-01-04 | 2019-01-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2018-11-29 | 2018-11-30 | 1,850 | — | $0 | 88,108 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-07-10 | 2018-07-11 | 26,127 | $17.94 | $468.7K | 89,958 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-07-09 | 2018-07-11 | 5,291 | $17.56 | $92.9K | 116,085 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-31 | 2018-04-03 | 4,418 | $22.90 | $101.2K | 136,376 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-31 | 2018-04-13 | 4,418 | $22.90 | $101.2K | 121,376 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2018-01-25 | 2018-01-26 | 48,882 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2018-01-25 | 2018-01-26 | 48,882 | $4.58 | $223.9K | 151,860 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-01-25 | 2018-01-26 | 11,066 | $20.23 | $223.9K | 140,794 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2018-01-04 | 2018-01-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2017-11-15 | 2017-11-15 | 1,100 | — | $0 | 102,978 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2017-11-14 | 2017-11-15 | 4,215 | — | $0 | 48,882 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2017-11-14 | 2017-11-15 | 4,215 | $4.58 | $19.3K | 105,117 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2017-11-14 | 2017-11-15 | 1,039 | $18.57 | $19.3K | 104,078 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2017-07-06 | 2017-07-10 | 60,000 | — | $0 | 100,902 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2017-03-08 | 2017-03-09 | 2,098 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2017-03-08 | 2017-03-09 | 2,098 | $1.13 | $2.4K | 41,049 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2017-03-08 | 2017-03-09 | 147 | $16.04 | $2.4K | 40,902 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2017-01-04 | 2017-01-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2016-12-06 | 2016-12-07 | 7,100 | — | $0 | 2,098 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2016-12-06 | 2016-12-07 | 7,100 | $1.13 | $8.0K | 39,848 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2016-12-06 | 2016-12-07 | 897 | $8.94 | $8.0K | 38,951 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2016-11-29 | 2016-12-07 | 1,000 | — | $0 | 32,748 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2016-01-07 | 2016-01-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2015-11-11 | 2015-11-12 | 9,200 | — | $0 | 9,198 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2015-11-11 | 2015-11-12 | 456 | $22.78 | $10.4K | 33,748 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2015-11-11 | 2015-11-12 | 9,200 | $1.13 | $10.4K | 34,204 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2015-11-02 | 2015-11-03 | 23,216 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2015-11-02 | 2015-11-03 | 23,216 | $0.57 | $13.2K | 48,220 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-11-02 | 2015-11-03 | 23,216 | $24.29 | $563.9K | 25,004 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2015-09-14 | 2015-09-15 | 17,000 | — | $0 | 18,398 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2015-09-14 | 2015-09-15 | 17,000 | $1.13 | $19.2K | 26,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2015-09-14 | 2015-09-15 | 996 | $19.27 | $19.2K | 25,004 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2015-03-11 | 2015-03-12 | 46,430 | — | $0 | 23,216 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-03-11 | 2015-03-12 | 46,430 | $15.00 | $696.5K | 10,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2015-03-11 | 2015-03-12 | 46,430 | $0.57 | $26.5K | 56,430 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2014-06-10 | 2014-06-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2014-05-29 | 2014-06-02 | 10,000 | — | $0 | 69,646 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2014-05-29 | 2014-06-02 | 10,000 | $0.57 | $5.7K | 10,000 | SEC↗ |